Dyskeratosis congenita: a disorder of telomerase deficiency and its relationship to other diseases

References

• Drachtman RA, Alter BP. Dyskeratosis congenita: clinical and genetic heterogeneity. Report of a new case and review of the literature. Am. J. Pediatr. Hematol. Oncol.14(4), 297–304 (1992).
   PubMedGoogle Scholar
• Dokal I. Dyskeratosis congenita. A disease of premature ageing. Lancet358(Suppl.), S27 (2001).
   Google Scholar
• Marrone A, Dokal I. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev. Mol. Med.6(26), 1–23 (2004).
   PubMedGoogle Scholar
• Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood107, 2680–2685 (2006).
   PubMed Web of Science ®Google Scholar
• Heiss NS, Knight SW, Vulliamy TJ et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet.19(1), 32–38 (1998).
   PubMed Web of Science ®Google Scholar
• Jiang W, Middleton K, Yoon HJ, Fouquet C, Carbon J. An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules. Mol. Cell Biol.13(8), 4884–4893 (1993).
   PubMed Web of Science ®Google Scholar
• Meier UT, Blobel G. NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria. J. Cell Biol.127(6 Pt1), 1505–1514 (1994).
   PubMed Web of Science ®Google Scholar
• Ni J, Tien AL, Fournier MJ. Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell89(4), 565–573 (1997).
   PubMed Web of Science ®Google Scholar
• Youssoufian H, Gharibyan V, Qatanani M. Analysis of epitope-tagged forms of the dyskeratosis congenital protein (dyskerin): identification of a nuclear localization signal. Blood Cells Mol. Dis.25(5–6), 305–309 (1999).
   PubMedGoogle Scholar
• Filipowicz W, Pogacic V. Biogenesis of small nucleolar ribonucleoproteins. Curr. Opin. Cell Biol.14(3), 319–327 (2002).
   PubMed Web of Science ®Google Scholar
• Meier UT. The many facets of H/ACA ribonucleoproteins. Chromosoma114(1), 1–14 (2005).
   PubMedGoogle Scholar
• Lafontaine DL, Bousquet-Antonelli C, Henry Y, Caizergues-Ferrer M, Tollervey D. The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev.12(4), 527–537 (1998).
   PubMed Web of Science ®Google Scholar
• Zebarjadian Y, King T, Fournier MJ, Clarke L, Carbon J. Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol. Cell Biol.19(11), 7461–7472 (1999).
   PubMed Web of Science ®Google Scholar
• Marrone A, Walne A, Dokal I. Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr. Opin. Genet. Dev.15(3), 249–257 (2005).
   PubMed Web of Science ®Google Scholar
• Tollervey D, Kiss T. Function and synthesis of small nucleolar RNAs. Curr. Opin. Cell Biol.9(3), 337–342 (1997).
   PubMed Web of Science ®Google Scholar
• Luzzatto L, Karadimitris A. Dyskeratosis and ribosomal rebellion. Nat. Genet.19(1), 6–7 (1998).
   PubMedGoogle Scholar
• He J, Navarrete S, Jasinski M et al. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene21(50), 7740–7744 (2002).
   PubMed Web of Science ®Google Scholar
• Ruggero D, Grisendi S, Piazza F et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science299(5604), 259–262 (2003).
   PubMed Web of Science ®Google Scholar
• Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ, Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc. Natl Acad. Sci. USA101(29), 10756–10761 (2004).
   PubMed Web of Science ®Google Scholar
• Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature402(6761), 551–555 (1999).
   PubMed Web of Science ®Google Scholar
• Montanaro L, Chilla A, Trere D et al. Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines. J. Invest. Dermatol.118(1), 193–198 (2002).
   PubMedGoogle Scholar
• Rashid R, Liang B, Baker DL et al. Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita. Mol. Cell21(2), 249–260 (2006).
   PubMed Web of Science ®Google Scholar
• Vulliamy T, Marrone A, Goldman F et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature413(6854), 432–435 (2001).
   PubMed Web of Science ®Google Scholar
• Blackburn EH. Structure and function of telomeres. Nature350(6319), 569–573 (1991).
   PubMed Web of Science ®Google Scholar
• Greider CW. Telomere length regulation. Ann. Rev. Biochem.65, 337–365 (1996).
   PubMed Web of Science ®Google Scholar
• Keith WN, Bilsland A, Evans TR, Glasspool RM. Telomerase-directed molecular therapeutics. Expert Rev. Mol. Med.22, 1–25 (2002).
   Google Scholar
• Vulliamy T, Marrone A, Dokal I, Mason PJ. Association between aplastic anaemia and mutations in telomerase RNA. Lancet359(9324), 2168–2170 (2002).
   PubMed Web of Science ®Google Scholar
• Chen JL, Blasco MA, Greider CW, Secondary structure of vertebrate telomerase RNA. Cell100(5), 503–514 (2000).
   PubMed Web of Science ®Google Scholar
• Chen JL, Greider CW. Telomerase RNA structure and function: implications for dyskeratosis congenita. Trends Biochem. Sci.29(4), 183–192 (2004).
   PubMedGoogle Scholar
• Theimer CA, Finger LD, Trantirek L, Feigon J. Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc. Natl Acad. Sci. USA100(2), 449–454 (2003).
   PubMedGoogle Scholar
• Comolli LR, Smirnov I, Xu L, Blackburn EH, James TL. A molecular switch underlies a human telomerase disease. Proc. Natl Acad. Sci. USA99(26), 16998–17003 (2002).
   PubMedGoogle Scholar
• Ly H, Blackburn EH, Parslow TG. Comprehensive structure-function analysis of the core domain of human telomerase RNA. Mol. Cell Biol.23(19), 6849–6856 (2003).
   PubMedGoogle Scholar
• Fu D, Collins K. Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs. Mol. Cell11(5), 1361–1372 (2003).
   PubMedGoogle Scholar
• Ren X, Gavory G, Li H, Ying L, Klenerman D, Balasubramanian S. Identification of a new RNA.RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation. Nucleic Acids Res.31(22), 6509–6515 (2003).
   PubMedGoogle Scholar
• Theimer CA, Finger LD, Feigon J. YNMG tetraloop formation by a dyskeratosis congenita mutation in human telomerase RNA. RNA9(12), 1446–1455 (2003).
   PubMedGoogle Scholar
• Marrone A, Stevens D, Vulliamy T, Dokal I, Mason PJ. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood104(13), 3936–3942 (2004).
   PubMed Web of Science ®Google Scholar
• Martin-Rivera L, Blasco MA. Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system. J. Biol. Chem.276(8), 5856–5865 (2001).
   PubMed Web of Science ®Google Scholar
• Wilson DB, Ivanovich J, Whelan A, Goodfellow PJ, Bessler M. Human telomerase RNA mutations and bone marrow failure. Lancet361(9373), 1993–1994 (2003).
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Calado RT, Ly H et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med.352(14), 1413–1424 (2005).
   PubMed Web of Science ®Google Scholar
• Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol. Dis.34(3), 257–263 (2005).
   PubMed Web of Science ®Google Scholar
• Armanios M, Chen JL, Chang YP et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA102(44), 15960–15964 (2005).
   PubMed Web of Science ®Google Scholar
• Blackburn EH, Greider CW, Henderson E, Lee MS, Shampay J, Shippen-Lentz D. Recognition and elongation of telomeres by telomerase. Genome31(2), 553–560 (1989).
   PubMedGoogle Scholar
• Shippen-Lentz D, Blackburn EH. Functional evidence for an RNA template in telomerase. Science247(4942), 546–552 (1990).
   PubMed Web of Science ®Google Scholar
• Autexier C, Greider CW. Functional reconstitution of wild-type and mutant Tetrahymena telomerase. Genes Dev.8(5), 563–575 (1994).
   PubMedGoogle Scholar
• Walne AJ, Marrone A, Dokal I. Dyskeratosis congenita: a disorder of defective telomere maintenance? Int. J. Hematol.82(3), 184–189 (2005).
   PubMedGoogle Scholar
• Devriendt K, Matthijs G, Legius E et al. Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am. J. Hum. Genet.60(3), 581–587 (1997).
   PubMedGoogle Scholar
• Vulliamy TJ, Knight SW, Dokal I, Mason PJ. Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood90(6), 2213–2216 (1997).
   PubMed Web of Science ®Google Scholar
• Ben Porath I, Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest.113(1), 8–13 (2004).
   PubMed Web of Science ®Google Scholar
• Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature345(6274), 458–460 (1990).
   PubMed Web of Science ®Google Scholar
• Colgin LM, Reddel RR. Telomere maintenance mechanisms and cellular immortalization. Curr. Opin. Genet. Dev.9(1), 97–103 (1999).
   PubMedGoogle Scholar
• Masutomi K, Yu EY, Khurts S et al. Telomerase maintains telomere structure in normal human cells. Cell114(2), 241–253 (2003).
   PubMed Web of Science ®Google Scholar
• Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis.27(2), 353–357 (2001).
   PubMed Web of Science ®Google Scholar
• Colvin BT, Baker H, Hibbin JA, Gordon-Smith EC, Gordon M. Haemopoietic progenitor cells in dyskeratosis congenita. Br. J. Haematol.56(3), 513–515 (1984).
   PubMedGoogle Scholar
• Friedland M, Lutton JD, Spitzer R, Levere RD. Dyskeratosis congenita with hypoplastic anemia: a stem cell defect. Am. J. Hematol.20(1), 85–87 (1985).
   PubMedGoogle Scholar
• Marley SB, Lewis JL, Davidson RJ et al. Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children. Br. J. Haematol.106(1), 162–166 (1999).
   PubMed Web of Science ®Google Scholar
• Marsh JC, Will AJ, Hows JM et al. “Stem cell” origin of the hematopoietic defect in dyskeratosis congenita. Blood79(12), 3138–3144 (1992).
   PubMed Web of Science ®Google Scholar
• Hathcock KS, Hemann MT, Opperman KK, Strong MA, Greider CW, Hodes RJ. Haploinsufficiency of mTR results in defects in telomere elongation. Proc. Natl Acad. Sci. USA99(6), 3591–3596 (2002).
   PubMedGoogle Scholar
• Chiang YJ, Hemann MT, Hathcock KS et al. Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Mol. Cell Biol.24(16), 7024–7031 (2004).
   PubMed Web of Science ®Google Scholar
• Blasco MA, Lee HW, Hande MP et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell91(1), 25–34 (1997).
   PubMed Web of Science ®Google Scholar
• Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature392(6676), 569–574 (1998).
   PubMed Web of Science ®Google Scholar
• Rudolph KL, Chang S, Lee HW et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell96(5), 701–712 (1999).
   PubMed Web of Science ®Google Scholar
• Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood91(9), 3255–3262 (1998).
   PubMed Web of Science ®Google Scholar
• Allsopp RC, Weissman IL. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene21(21), 3270–3273 (2002).
   PubMed Web of Science ®Google Scholar
• Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet.36(5), 447–449 (2004).
   PubMed Web of Science ®Google Scholar
• Artandi SE, Chang S, Lee SL et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature406(6796), 641–645 (2000).
   PubMed Web of Science ®Google Scholar
• Scappaticci S, Fraccaro M, Cerimele D. Chromosome abnormalities in dyskeratosis congenita. Am. J. Med. Genet.34(4), 609–610 (1989).
   PubMed Web of Science ®Google Scholar
• Dokal I, Bungey J, Williamson P, Oscier D, Hows J, Luzzatto L. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood80(12), 3090–3096 (1992).
   PubMed Web of Science ®Google Scholar
• Kehrer H, Krone W, Schindler D, Kaufmann R, Schrezenmeier H. Cytogenetic studies of skin fibroblast cultures from a karyotypically normal female with dyskeratosis congenita. Clin. Genet.41(3), 129–134 (1992).
   PubMed Web of Science ®Google Scholar
• Demiroglu H, Alikasifoglu M, Dundar S. Dyskeratosis congenita with an unusual chromosomal abnormality. Br. J. Haematol.97(1), 243–244 (1997).
   PubMedGoogle Scholar
• Dror Y, Shwachman-Diamond syndrome. Pediatr. Blood Cancer45(7), 892–901 (2005).
   PubMed Web of Science ®Google Scholar
• Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC. Progressive telomere shortening in aplastic anemia. Blood91(10), 3582–3592 (1998).
   PubMed Web of Science ®Google Scholar
• Brummendorf TH, Rufer N, Holyoake TL et al. Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders. Ann. NY Acad. Sci.938, 293–303 (2001).
   PubMed Web of Science ®Google Scholar
• Hofmann WK, Koeffler HP. Myelodysplastic syndrome. Ann. Rev. Med.56, 1–16 (2005).
   PubMed Web of Science ®Google Scholar
• Saba HI, Wijermans PW. Decitabine in myelodysplastic syndromes. Semin Hematol.42(3 Suppl. 2), S23–S31 (2005).
   PubMed Web of Science ®Google Scholar
• Odero MD, Vizmanos JL, Roman JP et al. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome. Genes Chrom. Cancer35(1), 11–19 (2002).
   PubMedGoogle Scholar
• Song WJ, Sullivan MG, Legare RD et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet.23(2), 166–175 (1999).
   PubMed Web of Science ®Google Scholar
• Ganly P, Walker LC, Morris CM. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leuk. Lymphoma45(1), 1–10 (2004).
   PubMed Web of Science ®Google Scholar
• Matsuno N, Osato M, Yamashita N et al. Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype. Leukemia17(12), 2492–2499 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang A, Zheng C, Hou M et al. Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome. Am. J. Hum. Genet.72(4), 940–948 (2003).
   PubMedGoogle Scholar
• Gazda HT, Zhong R, Long L et al. RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br. J. Haematol.127(1), 105–113 (2004).
   PubMed Web of Science ®Google Scholar
• Puzianowska-Kuznicka M, Kuznicki J. Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing? Int. J. Biochem. Cell Biol.37(5), 947–960 (2005).
   PubMedGoogle Scholar
• Kitao S, Shimamoto A, Goto M et al. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat. Genet.22(1), 82–84 (1999).
   PubMed Web of Science ®Google Scholar
• Wang LL, Gannavarapu A, Kozinetz CA et al. Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J. Natl Cancer Inst.95(9), 669–674 (2003).
   PubMed Web of Science ®Google Scholar
• Johnson FB, Lombard DB, Neff NF et al. Association of the Bloom syndrome protein with topoisomerase IIIα in somatic and meiotic cells. Cancer Res.60(5), 1162–1167 (2000).
   PubMed Web of Science ®Google Scholar
• Hu P, Beresten SF, van Brabant AJ et al. Evidence for BLM and topoisomerase IIIα interaction in genomic stability. Hum. Mol. Genet.10(12), 1287–1298 (2001).
   PubMed Web of Science ®Google Scholar
• Shiratori M, Sakamoto S, Suzuki N et al. Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J. Cell Biol.144(1), 1–9 (1999).
   PubMed Web of Science ®Google Scholar
• Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: relation to aging. Proc. Natl Acad. Sci. USA92(1), 258–262 (1995).
   PubMed Web of Science ®Google Scholar
• Wyllie FS, Jones CJ, Skinner JW et al. Telemorase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet.24(1), 16–17 (2000).
   PubMed Web of Science ®Google Scholar
• Eriksson M, Brown WT, Gordon LB et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature423(6937), 293–298 (2003).
   PubMed Web of Science ®Google Scholar
• De Sandre-Giovannoli A, Bernard R, Cau P et al. Lamin a truncation in Hutchinson-Gilford progeria. Science300(5628), 2055 (2003).
   PubMed Web of Science ®Google Scholar
• Cao H, Hegele RA. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J. Hum. Genet.48(5), 271–274 (2003).
   PubMed Web of Science ®Google Scholar
• Mu D, Sancar A. Model for XPC-independent transcription-coupled repair of pyrimidine dimers in humans. J. Biol. Chem.272(12), 7570–7573 (1997).
   PubMed Web of Science ®Google Scholar
• Thompson LH, Hinz JM, Yamada NA, Jones NJ. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ. Mol. Mutagen45(2–3), 128–142 (2005).
   PubMed Web of Science ®Google Scholar
• McKenzie SB. Advances in understanding the biology and genetics of acute myelocytic leukemia. Clin. Lab. Sci.18(1), 28–37 (2005).
   PubMedGoogle Scholar
• Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res.72, 141–196 (1998).
   PubMed Web of Science ®Google Scholar
• Melki JR, Clark SJ. DNA methylation changes in leukaemia. Semin. Cancer Biol.12(5), 347–357 (2002).
   PubMed Web of Science ®Google Scholar
• Silverman LR, Demakos EP, Peterson BL et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group Br. J. Clin. Oncol.20(10), 2429–2440 (2002).
   PubMed Web of Science ®Google Scholar
• Silverman LR, Holland JF, Weinberg RS et al. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia7(Suppl. 1), 21–29 (1993).
   PubMed Web of Science ®Google Scholar
• Zagonel V, Lo RG, Marotta G et al. 5-Aza-2´-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromes. Leukemia7(Suppl. 1), 30–35 (1993).
   PubMed Web of Science ®Google Scholar
• Knight SW, Heiss NS, Vulliamy TJ et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am. J. Hum. Genet.65(1), 50–58 (1999).
   PubMed Web of Science ®Google Scholar
• Safa WF, Lestringant GG, Frossard PM. X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax56(11), 891–894 (2001).
   Google Scholar
• Kanegane H, Kasahara Y, Okamura J et al. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita. Br. J. Haematol.129(3), 432–434 (2005).
   PubMed Web of Science ®Google Scholar
• Wong JM, Kyasa MJ, Hutchins L, Collins K. Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum. Genet.115(5), 448–455(2004).
   PubMedGoogle Scholar
• Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I. A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Br. J. Haematol.119(3), 765–768 (2002).
   PubMed Web of Science ®Google Scholar
• Heiss NS, Megarbane A, Klauck SM et al. One novel and two recurrent missense DKC1 mutations in patients with dyskeratosis congenita (DKC). Genet. Couns.12(2), 129–136 (2001).
   PubMedGoogle Scholar
• Knight SW, Heiss NS, Vulliamy TJ et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br. J. Haematol.107(2), 335–339 (1999).
   PubMed Web of Science ®Google Scholar
• Sznajer Y, Baumann C, David A et al. Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur. J. Pediatr.162(12), 863–867 (2003).
   PubMedGoogle Scholar
• Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum. Genet.108(4), 299–303 (2001).
   PubMed Web of Science ®Google Scholar
• Rostamiani K, Heiss N, Poustka A, Metzenberg A. Novel missense mutations in the DKC1 gene in patients with dyskeratosis congenita. Am. J. Hum. Genet.65, A488 (1999).
   Google Scholar
• Kraemer DM, Goebeler M. Missense mutation in a patient with X-linked dyskeratosis congenita. Haematologica88(4), ECR11 (2003).
   PubMedGoogle Scholar
• Yaghmai R, Kimyai-Asadi A, Rostamiani K et al. Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J. Pediatr.136(3), 390–393 (2000).
   PubMedGoogle Scholar
• Lin JH, Lee JY, Tsao CJ, Chao SC. DKC1 gene mutation in a Taiwanese kindred with X-linked dyskeratosis congenita. Kaohsiung J. Med. Sci.18(11), 573–577 (2002).
   PubMedGoogle Scholar
• Viprakasit V, Tanphaichitr VS. Recurrent A353V mutation in a Thai family with X-linked dyskeratosis congenita. Haematologica86(8), 871–872 (2001).
   PubMedGoogle Scholar
• Hiramatsu H, Fujii T, Kitoh T et al. A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita. Pediatr. Hematol. Oncol.19(6), 413–419 (2002).
   PubMed Web of Science ®Google Scholar
• Ding YG, Zhu TS, Jiang W et al. Identification of a novel mutation and a de novo mutation in DKC1 in two Chinese pedigrees with dyskeratosis congenita. J. Invest. Dermatol.123(3), 470–473 (2004).
   PubMedGoogle Scholar
• Vulliamy TJ, Knight SW, Heiss NS et al. Dyskeratosis congenita caused by a 3´ deletion: germline and somatic mosaicism in a female carrier. Blood94(4), 1254–1260 (1999).
   Google Scholar
• Ly H, Schertzer M, Jastaniah W et al. Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood106(4), 1246–1252 (2005).
   PubMedGoogle Scholar
• Yamaguchi H, Baerlocher GM, Lansdorp PM et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood102(3), 916–918 (2003).
   PubMed Web of Science ®Google Scholar
• Ly H, Calado RT, Allard P et al. Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood105(6), 2332–2339 (2005).
   PubMed Web of Science ®Google Scholar
• Fogarty PF, Yamaguchi H, Wiestner A et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet362(9396), 1628–1630 (2003).
   PubMed Web of Science ®Google Scholar
• Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet.6(6), 921–926 (1997).
   PubMed Web of Science ®Google Scholar
• Savage SA, Stewart BJ, Eckert A, Kiley M, Liao JS, Chanock SJ. Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint. Hum. Mutat.26(4), 343–350 (2005).
   PubMedGoogle Scholar